# Junta clínica — PT-pseudo_95d3fd02d5e0 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_95d3fd02d5e0",
  "pid": "PT-pseudo_95d3fd02d5e0",
  "task": 1,
  "psa": 5.5,
  "age": 63,
  "months": 3,
  "pirads": "4",
  "psad": 0.11,
  "psav": 0.77,
  "psap": 5.4,
  "vol": 48.0,
  "dre": "Normal",
  "bx": "Positive",
  "cspca": 0.6454933,
  "medhx": "Type 2 diabetes, Coronary artery disease",
  "meds": "metformin, empagliflozin, aspirin 80 mg",
  "notes": "PSA 5.5 ng/mL. PI-RADS 4. PSAD 0.11. Prostate volume 48 mL. csPCa 0.65.",
  "pmhx": [
    "Type 2 diabetes",
    "Coronary artery disease"
  ],
  "allergies": [],
  "vitals": {
    "weight": "88 kg",
    "height": "181 cm",
    "bmi": "26.9",
    "bp": "160/82 mmHg",
    "hr": "66 bpm",
    "smoking": "Non-smoker",
    "last_dental": "2 yr ago",
    "flu_vax": "Nov 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "16 Feb 2025",
  "enc_ref": "Dr. K. Bakker (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Clinical assessment required due to persistently elevated prostate-specific antigen levels and a previous biopsy confirming malignancy."
    },
    {
      "s": "History",
      "t": "A 63-year-old retired bus driver initially entered investigation in mid-2023 after PSA markers began climbing. He abstains from tobacco and alcohol entirely. His medical background includes type 2 diabetes, currently controlled with metformin and empagliflozin, alongside coronary artery disease managed via daily aspirin 80 mg. Severe lower urinary tract symptoms have persisted for years, yielding an IPSS score of 28 out of 35. He covers roughly 20 kilometres on his bicycle twice weekly. Quarterly consultations with a diabetes nurse remain routine, complemented by a recently finished six-session physiotherapy regimen for mechanical lower back pain. Chronic shoulder discomfort is also monitored through a specialized pain clinic. Widowed, he shares a home with his partner and maintains a flexible timetable that easily accommodates his outpatient visits."
    },
    {
      "s": "Physical examination",
      "t": "DRE: Examination reveals a normal prostate profile; the gland is symmetrically enlarged with a smooth, firm consistency and lacks any palpable nodules or asymmetry. Vital parameters remain stable; blood pressure reads 160/82 mmHg while the cardiac rhythm is regular at 66 beats per minute. General observation notes a well-nourished individual free of acute distress, with clear pulmonary fields and consistent heart sounds upon auscultation."
    }
  ],
  "occupation": "retired bus driver",
  "marital": "Widowed",
  "living": "Lives with partner",
  "next_of_kin": "Adult son (primary contact)",
  "recent_other": [
    "Diabetes nurse — quarterly review",
    "Physiotherapy — lower back, six sessions",
    "Pain clinic — chronic shoulder pain"
  ],
  "alcohol": "0 units / week (alcohol-free)",
  "exercise": "Cycling 2x/week, ~20 km",
  "ipss": "IPSS score: 28/35 (severe LUTS)",
  "admin": "Patient self-employed; flexible appointment slots requested.",
  "mri_hospital": "Maastricht UMC+",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_95d3fd02d5e0
Task: 1

Encounter: Urology - outpatient on 16 Feb 2025.
Referrer: Dr. K. Bakker (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 63-year-old male
  - PSA: 5.5 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.11 ng/mL²
  - PSA velocity: 0.77 ng/mL/yr
  - Prior PSA: 5.4 ng/mL
  - Prostate volume: 48.0 mL
  - Months since last PSA: 3
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.6454933 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Type 2 diabetes, Coronary artery disease
  - Problem list / PMHx: Type 2 diabetes, Coronary artery disease
  - Current medication: metformin, empagliflozin, aspirin 80 mg
  - Allergies: NKA
  - Additional notes: PSA 5.5 ng/mL. PI-RADS 4. PSAD 0.11. Prostate volume 48 mL. csPCa 0.65.

Vitals: weight 88 kg, height 181 cm, BMI 26.9, BP 160/82 mmHg, HR 66 bpm. Smoking: Non-smoker.

Chief complaint: Clinical assessment required due to persistently elevated prostate-specific antigen levels and a previous biopsy confirming malignancy.

History: A 63-year-old retired bus driver initially entered investigation in mid-2023 after PSA markers began climbing. He abstains from tobacco and alcohol entirely. His medical background includes type 2 diabetes, currently controlled with metformin and empagliflozin, alongside coronary artery disease managed via daily aspirin 80 mg. Severe lower urinary tract symptoms have persisted for years, yielding an IPSS score of 28 out of 35. He covers roughly 20 kilometres on his bicycle twice weekly. Quarterly consultations with a diabetes nurse remain routine, complemented by a recently finished six-session physiotherapy regimen for mechanical lower back pain. Chronic shoulder discomfort is also monitored through a specialized pain clinic. Widowed, he shares a home with his partner and maintains a flexible timetable that easily accommodates his outpatient visits.

Physical examination: DRE: Examination reveals a normal prostate profile; the gland is symmetrically enlarged with a smooth, firm consistency and lacks any palpable nodules or asymmetry. Vital parameters remain stable; blood pressure reads 160/82 mmHg while the cardiac rhythm is regular at 66 beats per minute. General observation notes a well-nourished individual free of acute distress, with clear pulmonary fields and consistent heart sounds upon auscultation.

Patient info: retired bus driver; Widowed; Lives with partner.
Next of kin: Adult son (primary contact).

Lifestyle: alcohol 0 units / week (alcohol-free); exercise Cycling 2x/week, ~20 km; IPSS score: 28/35 (severe LUTS).

Recent other appointments: Diabetes nurse — quarterly review; Physiotherapy — lower back, six sessions; Pain clinic — chronic shoulder pain.
Admin: Patient self-employed; flexible appointment slots requested.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: NO BIOPSY   p(biopsy) = 0.48
  uncertainty  +/- 0.11 epistemic (95% band 0.27-0.68); among patients I cannot tell apart the outcome was 1.00 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = 2 on the problem list (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 63 (2% of my signal; from age) · DRE = Normal (10% of my signal; from dre_suspicious) · PSA = 5.5 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 48 mL (1% of my signal; from log_vol, vol) · PSA density = 0.11 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.65 (1% of my signal; from cspca) · PI-RADS = 4 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  important  prior biopsy = Positive
  noted      age = 63 · DRE = Normal · PSA = 5.5 ng/mL · prostate volume = 48 mL · PSA density = 0.11 · PI-RADS = 4 · comorbidity = 2 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: uncertain — none of my three panel rules applies; the fact that would settle it — the documented prior grade — lives in the notes, not on the panel

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 49 labelled men in this same situation (Positive prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 0.43: PI-RADS 4, PSA 6.5, PSAD 0.11, age 64, DRE Normal -> DEFER (uncertain). He wrote: "Need initial ISUP grade and MRI in men on active surveillance."
  2. distance 0.57: PI-RADS 4, PSA 5.3, PSAD 0.092, age 65, DRE Normal -> BIOPSY (clear). He wrote: "P4 in 65 years old patient"
  3. distance 0.87: PI-RADS 4, PSA 4.7, PSAD 0.07, age 59, DRE Normal -> DEFER (uncertain). He wrote: "PRADS 4 with low-PSA-density can be followed up, I need results of earlier biopsy to make a definite call"

PRECEDENT: DEFER (weighted vote 0.34 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  important  prior biopsy = Positive · age = 63 · PI-RADS = 4
  noted      family history = not opened (0 of 91) · DRE = Normal · PSA = 5.5 ng/mL · prostate volume = 48 mL · PSA density = 0.11 · comorbidity = 2 on the problem list
  not used   csPCa probability
CONFIDENCE: uncertain — in this situation the library is no better than chance (47% out of fold)

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes, laboratory_results.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  important  prior biopsy = Positive · age = 63 · PSA = 5.5 ng/mL · PI-RADS = 4
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 48 mL · PSA density = 0.11 · comorbidity = 2 on the problem list
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The retrieved guideline discusses using PI-RADS thresholds to guide biopsy decisions, noting that a threshold of PI-RADS $\ge 3$ is used to trigger biopsy, and that increasing the threshold to $\ge 4$ could avoid a significant number of biopsies while missing some cancer.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, your variable 'prior biopsy = Positive' is marked decisive, whereas the guideline treats this as context, and the guideline suggests the decision relies on PI-RADS thresholds. The guideline suggests that for this patient, the decision should be guided by the PI-RADS score and PSA density, rather than the prior biopsy status. The guideline requires the PI-RADS score and PSA density to guide the decision. The guideline needs the prior grade of the prior biopsy to determine the next step.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the documented grade of the prior biopsy: at ISUP 2 or above the guideline sends him to treatment, not to more tissue; if it is unrecorded the indication stands
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges on establishing the documented grade of the prior biopsy, as the guideline suggests this, and the previous notes are crucial for that.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Determine whether the lesion is compared against an earlier study.
  psa_trend (get_psa_trend) -> Determine the trajectory of the serial PSA values.
  previous_notes (get_previous_notes) -> Determine the documented grade of the prior biopsy and surveillance status.
  laboratory_results (get_lab_results) -> Determine the DRE finding filing.

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the documented grade of the prior biopsy?
  Q2. Does the lesion in the radiology_report show change compared to an earlier study?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
Maastricht UMC+ Radiology Division | 10 February 2025 | Modality: Multiparametric MRI of the Prostate. The lesion is compared against an earlier study: new. LESION: A discrete focus sits in the posterior right mid-gland peripheral zone, spanning 14 x 10 x 12 mm.
psa_trend
PSA 2.1 (Jul 2023) rising to 5.5 (Feb 2025), steepest in the last year.
previous_notes
PRIOR GRADE: not recorded. BIOPSY SESSIONS: not recorded. SURVEILLANCE: not recorded. TREATMENT: none recorded.
laboratory_results
DRE finding filing: Normal.

WHAT I DID NOT OPEN
family-history anamnesis, because the documented prior biopsy status and surveillance history are the immediate focus for the decision.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS 4 lesion in the right mid-gland peripheral zone, as per radiology_report.
PSA 5.5 ng/mL with a rising trend, as per psa_trend.
AGAINST sampling this patient now
Prior biopsy status is not documented in previous_notes, which is crucial for the decision.

WHERE THIS LEANS
LEAN: unclear

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 5.50 ng/mL over 5 points spanning 19 months; velocity +2.14 ng/mL per year; doubling time about 14 months.
PROJECTION at 6 months: 7.3 ng/mL, conformal 95% band 2.1-25.4.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 5.5 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report and the laboratory panel; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.64
  uncertainty  +/- 0.08 epistemic (95% band 0.48-0.81), of which 0.00 comes from values that had to be imputed
  reliability  MODERATE ('supports' tier) — out-of-fold it was right 71% of the time over the 24 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 4 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      DRE = Normal (5% of my signal; from dre_suspicious) · PSA = 5.5 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 48 mL (4% of my signal; from log_vol, vol) · PSA density = 0.11 (0% of my signal; from psad_calc) · comorbidity = 2 on the problem list (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, csPCa probability
CONFIDENCE: borderline — 'supports' tier; out-of-fold it was right 71% of the time over the 24 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  DEFER, p(biopsy)=0.48  ('discuss' tier; weight 1.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.64  ('supports' tier, fusion_full; weight 3.0)
  EXPERT-LIBRARY     DEFER, p(biopsy)=0.34  (k=3 precedents; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: weighted vote of the trained experts, p = 0.60 — carried by weighted panel.
PANEL ANSWER: BIOPSY. EXPERT-FUSION carried the most weight ('supports' tier, fusion_full). In this bucket no rule applied and the documents did not record the prior grade, so the trained experts decide.
Dissenting on the board: EXPERT-STRUCTURED, EXPERT-LIBRARY. Their bids are recorded above; they did not carry because a higher rung of the protocol applied.

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Positive                     E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> important
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          63                           E1:not E3:— cohort:not library:IMP E2:—              -> important
  dre          Normal                       E1:not E3:not cohort:not library:not E2:—            -> noted
  psa          5.5 ng/mL                    E1:not E3:not cohort:not library:not E2:not          -> important
  vol          48 mL                        E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.11                         E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.65                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       4                            E1:not E3:IMP cohort:not library:IMP E2:—            -> important
  comorbidity  2 on the problem list        E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: borderline.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes, laboratory_results) address the moderator's questions. The `previous_notes` explicitly state that the documented prior grade is "not recorded," and the `radiology_report` indicates the lesion is "new" compared to an earlier study.

ALIGNMENT WITH THE PANEL
The PANEL-PROTOCOL concluded BIOPSY based on a weighted vote, despite the lack of a documented prior grade. The retrieved evidence, specifically the finding that the prior biopsy status is "not recorded" in the `previous_notes`, directly contradicts the condition under which the panel decided, which was the presence of a documented prior grade.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the documented grade of the prior biopsy? Answered by the `previous_notes`: "PRIOR GRADE: not recorded."
Q2. Does the lesion in the radiology_report show change compared to an earlier study? Answered by the `radiology_report`: "The lesion is compared against an earlier study: new."

WHAT CARRIES WEIGHT, AND WHY
<prior biopsy>: not_used / not recorded, because the `previous_notes` state "PRIOR GRADE: not recorded," which is the critical missing piece the panel relied upon. I would move this to 'decisive' because the guideline emphasizes the prior grade.
<psa>: important / 5.5 ng/mL, because the `psa_trend` shows a rising trajectory, which is a relevant factor for the decision. I agree with the panel's weighting of PSA as important.
My confidence in the record as it stands is borderline, due to the critical lack of the prior biopsy grade.

MY SUGGESTION TO THE CHAIR
Given that the critical piece of information—the documented prior biopsy grade—is explicitly missing, and the guideline suggests this is crucial, I suggest deferring to obtain the prior biopsy grade before making a definitive decision.

VERDICT: not-ready | SUGGEST: defer | MISSING: none

[The conference closes after pass 1: every document on the plan is open; nothing outside the plan is ever opened. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: borderline)

PI-RADS 4, PSA 5.5, and prior positive biopsy with unrecorded grade suggest sampling is warranted. The lack of prior biopsy grade prevents definitive risk stratification. The patient has significant comorbidities, but the new MRI finding warrants tissue sampling for management planning.

What carried weight: bx=important, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes, laboratory_results
